Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Quick take on safety: bonds vs cash in retirement, highlighting scenarios where each preserves capital and meets withdrawal needs.
24,731 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Upwork stock has fallen this year as a big investor sold a multi-million stake, raising questions about the company’s...
When a top executive sells a large block of shares, investors want clarity. This guide breaks down what RingCentral's...
A hedge fund famous for bold bets shows a striking concentration: nearly half of its $14 billion stock portfolio sits...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
As the 2026 earnings season unfolds, investors want real, actionable insights on fidus (FDUS) 2026 earnings. This ana...
Barclays boosts its view on Charles Schwab after the firm guides for higher 2026 revenue and reports stronger Q1 resu...
A new move from Google signals a shift in AI compute. This could tilt the balance away from Nvidia in certain cloud a...
NVIDIA stock is approaching its 52-week high as AI-driven demand sustains a rally across the tech sector. Analysts we...
SpaceX stock just opened with an eye-catching $150 price, an 11% jump from the IPO price of $135. This article breaks...
A seasoned Mission Produce director just bought a substantial block of shares, signaling confidence in AVO. This arti...